| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer | Chief Business Officer
1 company
Serafin Andrew is a Chief Strategy Officer at HRMY. Recent filings cover 0 purchases and 2 sales. Those positions are worth an estimated $65K at current prices.
Serafin Andrew's largest disclosed position is in HRMY as Chief Strategy Officer, worth about $65K. The recent filings there lean toward selling, a net 38,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | HRMY Harmony Biosciences Holdings, Inc. | Chief Strategy Officer | Sale+OE | 38,000 | $60.13 | $2,285,099.92 | -97.6% | -29.0% | -49.6% |